The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.
Name: Serious Illness Conversation Guide (SICG)
Name: Quality of Life (QOL) survey
Description: Difference in proportions of patients who have documented goals of care in medical records, assessed after death, for both arms
Measure: Difference in proportions of patients with documented goals of care Time: 1 yearDescription: Proportion of patients receiving appropriate care in line with their goals of care toward the end of life, by arm will be assessed.
Measure: Difference in proportions of patients with appropriate care toward end of life Time: 1 yearDescription: Comparison of survey QOL measures by section for control and intervention arms will be done by Functional Assessment of Cancer Therapy (FACT-G) , version 4 scale. It is a 28-item validated QoL questionnaire in patients receiving cancer treatment. All subscales are summed together to arrive at a total score. A higher point value is considered a better quality of life score
Measure: Comparison of QOL survey measures by section Time: 1 yearDescription: Comparison of survey QOL measures overall for control and intervention arms will be done by Functional Assessment of Cancer Therapy (FACT-G) , version 4 scale. It is a 28-item validated QoL questionnaire in patients receiving cancer treatment. All subscales are summed together to arrive at a total score. A higher point value is considered a better quality of life score
Measure: Overall comparison of QOL survey Time: 1 yearAllocation: Randomized
Parallel Assignment
There is one SNP
- Exception: Patients with metastatic colorectal cancer whose tumors demonstrate a BRAF V600E mutation may be enrolled regardless of prior chemotherapy. --- V600E ---